Imatinib metabolite N-Desmethyl Imatinib is an N-demethylated metabolite of Imatinib (gleevec), which is a BCR-ABL inhibitor approved for treating chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL).

纯度：≥98%

CAS：404844-02-6